Vol 55, No 1 (2021)
Response to Letter to the Editors
Published online: 2020-10-07
A comment on the paper ‘Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors’ by Sapko et al.
Abstract
Not available
References
- Lewczuk P, Kornhuber J, Mroczko BA, et al. comment to the paper "Biomarkers in Multiple Sclerosis" by Sapko. Neurol Neurochir Pol. ; 2020: 55.
- Sapko K, Jamroz-Wiśniewska A, Marciniec M, et al. Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors. Neurol Neurochir Pol. 2020; 54(3): 252–258.
- Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006; 180(1-2): 17–28.
- Gastaldi M, Zardini E, Leante R, et al. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci. 2017; 38(Suppl 2): 217–224.
- Pryce G, Baker D. Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter? Mult Scler Relat Disord. 2018; 25: 131–137.
- Lo Sasso B, Agnello L, Bivona G, et al. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update. Medicina (Kaunas). 2019; 55(6).
